Edition:
India

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

10.28USD
7 Aug 2020
Change (% chg)

-- (--)
Prev Close
$10.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,668
52-wk High
$11.82
52-wk Low
$4.99

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Mar '20 0.00 -0.075
FY 2019 Dec '19 0.00 -0.330
Sep '19 0.00 -0.137
Jun '19 0.00 -0.428
Mar '19 0.00 -0.820
FY 2018 Dec '18 0.00 -0.380
Sep '18 0.00 -0.252
Jun '18 0.00 -0.454
Mar '18 0.00 -1.027
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-20 2 0.00 0.00 0.00 --
Quarter Ending Dec-20 2 0.00 0.00 0.00 --
Year Ending Dec-20 2 0.00 0.00 0.00 --
Year Ending Dec-21 2 19.43 28.40 10.45 16.58
Earnings (per share)
Quarter Ending Sep-20 2 -0.10 -0.07 -0.13 --
Quarter Ending Dec-20 2 -0.34 -0.30 -0.37 --
Year Ending Dec-20 2 -0.62 -0.59 -0.64 -0.91
Year Ending Dec-21 2 -0.85 0.12 -1.82 -1.52
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 33.53
P/E High - Last 5 Yrs. -- 40.50 45.20
P/E Low - Last 5 Yrs. -- 23.86 24.26
Beta -- 0.91 0.90
Price to Sales (TTM) -- 3.99 5.69
Price to Book (MRQ) 2.07 4.97 5.07
Price to Tangible Book (MRQ) 2.07 5.74 6.50
Price to Cash Flow (TTM) -- 23.03 23.51
% Owned Institutions 0.28 0.87 1.73

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.49
Dividend Yield - 5 Year Avg -- 1.56 1.51
Dividend 5 Year Growth Rate -- 4.28 5.14
Payout Ratio(TTM) -- 45.75 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.37 10.57
Sales (TTM) vs TTM 1 Yr. Ago -- 4.65 5.71
Sales - 5 Yr. Growth Rate -- 9.86 10.05
EPS (MRQ) vs Qtr. 1 Yr. Ago -212.06 16.29 20.17
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.10 14.97

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.33
Current Ratio (MRQ) 4.85 3.05 3.16
LT Debt to Equity (MRQ) 1.45 8.79 11.31
Total Debt to Equity (MRQ) 23.49 12.59 15.51
Interest Coverage (TTM) -- 41.12 36.66

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.55 54.39
Gross Margin - 5 Yr. Avg. -- 52.05 52.27
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.46 11.96
Operating Margin (TTM) -- 14.38 5.41
Operating Margin - 5 Yr. Avg. -- 14.55 7.51
Pre-Tax Margin (TTM) -- 14.90 6.29
Pre-Tax Margin - 5 Yr. Avg. -- 14.98 8.02
Net Profit Margin (TTM) -- 11.09 2.52
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.24
Effective Tax Rate (TTM) -- 23.42 23.33
Effective Tax Rate - 5 Yr. Avg. -- 23.64 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 978,598,613 879,042,975
Net Income/Employee (TTM) -- 116,081,974 104,231,326
Receivable Turnover (TTM) -- 5.78 5.98
Inventory Turnover (TTM) -- 2.66 3.45
Asset Turnover (TTM) -- 0.98 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.90 11.45
Return on Assets - 5 Yr. Avg. -- 13.16 12.56
Return on Investment (TTM) -- 15.42 14.93
Return on Investment - 5 Yr. Avg. -- 17.10 16.29
Return on Equity (TTM) -- 16.77 16.49
Return on Equity - 5 Yr. Avg. -- 18.03 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 39.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.72%
# of Holders: 43
Total Shares Held: 2,121,867
3 Mo. Net Change: 87,977
# New Positions: 16
# Closed Positions: 1
# Increased Positions: 18
# Reduced Positions: 2
# Net Buyers: 16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.